Company intelligence / Profile preview

Shanghai Vinnerna Biosciences Co., Ltd.

Shanghai, Shanghai Shi / Municipality directly under central government, Chinain.marketscreener.com ↗

Ownership: Private
Development stage: Commercial

Overview

Shanghai Vinnerna Biosciences is a subsidiary of Shanghai Junshi Biosciences focused on the development and commercialization of innovative small molecule drugs for infectious diseases. Its lead product, Deuremidevir Hydrobromide Tablets (VV116/MINDEWEI), an oral nucleoside analog targeting SARS-CoV-2 RdRp, received conditional approval in China for the treatment of mild to moderate COVID-19 in adults as of January 2023. The company has partnered with Zhejiang Huahai Pharmaceutical for manufacturing and supply[2][8]. Global registration efforts are ongoing.

Therapeutic areas: Infectious Diseases
Modalities: Small molecule drug
Industry: Biotech

Drug pipeline

1 asset

deuremidevir hydrobromide

Commercial

Indications: Mild to moderate COVID-19

Partnerships

Zhejiang Huahai Pharmaceutical Co., Ltd. [manufacturing/supply partnership][2]

Beyond the preview

Go deeper on Shanghai Vinnerna Biosciences Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Vinnerna Biosciences Co., Ltd..

Explore the full profile